Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1186/s13014-016-0644-4
Published Online: 2016-05-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leung, Henry W. C.
Liu, Chung-Feng
Chan, Agnes L. F.